Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles
- 22 April 2008
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 114 (2) , 377-384
Abstract
Background Tamoxifen (TAM) a non-steroidal antiestrogen, is widely used in adjuvant therapy for all stages of breast carcinomas and in chemoprevention of high-risk group. TAM also has estrogenic activity on liver and endometrium causing severe oxidative stress with various biochemical derangements. Coenzyme Q10, Riboflavin and Niacin (CoRN) are well-known potent antioxidants and protective agents against many diseases including cancer. In this context, this study was undertaken to find if co-administration of TAM along with CoRN could alleviate the sole TAM-induced biochemical derangements in postmenopausal women with breast cancer. Method The vitamin supplementation with TAM was given for a period of 90 days. Blood samples were collected at the base line, 45th and 90th day during the course of treatment. Various blood chemistry profiles were assessed in 78 untreated, sole TAM treated and combinatorial treated group along with 46 age- and sex-matched controls. Results A statistically significant alteration in various blood chemistry parameters, such as serum total bilirubin (S. BIL), serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), gamma glutamyl transpeptidase (γ-GT), uric acid (UA), lipoprotein lipase (LPL), lecithin: cholesterol acyl transferases (LCAT), potassium, calcium and Na+, K+-ATPase in sole TAM-treated group, was favorably reverted back to near normal levels on combinatorial therapy with CoRN. Conclusion TAM on co-administration with CoRN has a favorable impact on various blood chemistry profiles. However, large scale randomized studies over a longer time span are required to ascertain the safety and efficacy of co-administrating antioxidants with conventional chemotherapy.Keywords
This publication has 48 references indexed in Scilit:
- Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytesFree Radical Biology and Medicine, 2008
- Gene expression profiling reveals underlying molecular mechanisms of the early stages of tamoxifen-induced rat hepatocarcinogenesis☆Toxicology and Applied Pharmacology, 2007
- Leigh Syndrome with Nephropathy and CoQ10 Deficiency Due to decaprenyl diphosphate synthase subunit 2 (PDSS2) MutationsThe American Journal of Human Genetics, 2006
- Dietary Intake of Folate and Riboflavin, MTHFR C677T Genotype, and Colorectal Adenoma Risk: A Dutch Case-Control StudyCancer Epidemiology, Biomarkers & Prevention, 2005
- Energy-modulating vitamins – a new combinatorial therapy prevents cancer cachexia in rat mammary carcinomaBritish Journal of Nutrition, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosisEuropean Journal of Gastroenterology & Hepatology, 2004
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- 1.P.54 Molecular and environmental bases of primary type IV hyperlipoproteinemia: Heterozygous lipoprotein lipase deficiency as a causal genetic disorderAtherosclerosis, 1997
- A role of vitamin E in protection against cell injury. Maintenance of intracellular glutathione precursors and biosynthesisEuropean Journal of Biochemistry, 1987